Abstract
Ciclazindol, a new tetracyclic compound, appears to be a potentially important antidepressant of the same order as amitriptyline, but with significantly fewer, subjective side effects. Although as a group the patients treated with ciclazidol lost weight, clinical improvement was observed to be significantly corelated with the weight gain in both groups. The peripheral adrenergic interactions were studied. In the dosage used (100 mg/day) ciclazindol was observed to be a peripheral NA-reuptake blocker with no significant effect on the postsynaptic α-receptors.
Plasma concentrations of the drug were estimated and their relationship to the therapeutic outcome, side effects, and adrenergic interaction were studied.
No significant change in resting BP or ECG was observed following 4–6 weeks' treatment with ciclazindol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B., Sjoqvist, F., Price-Evans, D.A: Steady-state plasma levels of nortriptyline in twine. Influence of genetic factors and drug therapy. Br. Med. J. 1969IV, 764–766
Braithwaite, R.A., Goulding, R., Theano, G., Bailey, J., Coppen, A.: Plasma concentration of amitriptyline and clinical response. Lancet 1972I, 1297–1300
Burns, J.H., Rand, M.J.: The actions of sympathomimetic amines in animals treated with reserpine. J. Physiol. (Lond.) 144, 314–319 (1958)
Coppen, A., Gupta, R., Montgomery, S., Ghose, K., Bailey, J., Burns, B, de Ridder, J.J.: Mianserin hydrochloride: A novel antidepressant. Br. J. Psychiatry 129, 342–345 (1976)
Ghose, K.: Lithium salts: therapeutic and unwanted effects. Br. J. Hosp. Med. (in press, 1977)
Ghose, K., Coppen, A., Turner, P.: Autonomic actions and interactions of mianserin hydrochloride. Psychopharmacology 49, 201–204 (1976a)
Ghose, K., Gifford, L.A., Turner, P., Leighton, M.: Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose and its correlation with plasma concentration. Br. J. Clin. Pharmacol. 3, 334–336 (1976b)
Ghose, K., Gupta, R., Coppen, A., Lund, J.: Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patients. Eur. J. Pharmacol 42, 31–37 (1977)
Ghose, K., Turner, P., Coppen, A.: Intravenous tyramine pressor response in depression. Lancet 1975I, 1317–1318
Hamilton, M.: A rating scale for-depression. J. Neurol. Neurosurg. Psychiatry 23, 56 (1960)
Innes, I. R., Nickerson, M.: Drugs acting on postganglionic adrenergic nerve endings and structures innervated by them (sympathomimetic drugs). In: The pharmacological basis of therapeutics, 4th. ed., L.S. Goodman and A. Gilman, eds., p. 510. New York: MacMillan 1965
Klerman, G.L., Cole, J.O.: Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol. Rev. 17, 101–141 (1965)
Medical Research Council Clinical Psychiatry Committee (1965). Medical Research Council trial of the treatment of depressive illness. Br. Med. J. 1965I, 881–886
Siwers, B., Tuck, D., Freyschuss, U., Azarnoff, D.L., Sjoqvist, F.: A novel approach to the phase I clinical trial of tricyclic antidepressant drugs. Abstract for Fourth International Congress on Pharmacology (1969)
Sugden, R.F.: Action of indoramin and other compounds on the uptake of neurotransmitters into rat cortical slices. Br. J. Pharmacol. 51, 467–472 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghose, K., Rama Rao, V.A., Balley, J. et al. Antidepressant activity and pharmacological interactions of ciclazindol. Psychopharmacology 57, 109–114 (1978). https://doi.org/10.1007/BF00426966
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00426966